Stephanie Royer‐Joo
Stephanie Royer‐Joo publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.
- World rank
- #623,809 of 7,710,434 ranked researchers
- Rank in United States
- #213,264 of 1,627,098
- Works
- 65
- Citations
- 1.2k
- Citations per work
- 19.0
What does Stephanie Royer‐Joo research?
Stephanie Royer‐Joo's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4061.4%
- Medicine4061.4%
- Life Sciences1523.0%
- Everything else1015.6%
- 1Oncology35% of their works
- 2Pulmonary and Respiratory Medicine22% of their works
- 3Molecular Biology16% of their works
- 4Cancer Research4% of their works
- 5Genetics4% of their works
- 6Immunology3% of their works
Research topics
Which keywords describe Stephanie Royer‐Joo's research?
The keywords of their largest research topics: Metastatic Breast Cancer, Breast Cancer, CDK4/6 Inhibitors, Chemotherapy, Palbociclib, Targeted Therapy, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- Mutational Signatures
- Chronic Lymphocytic Leukemia
- KRAS Mutations
- mTOR
- EGFR Mutations
- Trastuzumab
- Taxanes
- Targeted Therapy
- Chemotherapy
- Breast Cancer
- Metastatic Breast Cancer
- CDK4/6 Inhibitors
- Palbociclib
- Chemotherapy-Induced Peripheral Neuropathy
- HER2
- ALK Inhibitors
- Signaling
- Cetuximab
- Cancer Genomics
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Metastatic Breast Cancer272 topics
- Breast Cancer242 topics
- CDK4/6 Inhibitors151 topic
- Chemotherapy152 topics
- Palbociclib151 topic
- Targeted Therapy132 topics
- Chemotherapy-Induced Peripheral Neuropathy121 topic
- Taxanes121 topic
- HER291 topic
- Trastuzumab91 topic
- ALK Inhibitors81 topic
- EGFR Mutations81 topic
- Signaling81 topic
- mTOR81 topic
- Cetuximab61 topic
- KRAS Mutations61 topic
- Cancer Genomics51 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Mutational Signatures51 topic
Where does Stephanie Royer‐Joo work?
Stephanie Royer‐Joo's main affiliation in the publication record is Sarah Cannon, United States.
How many publications and citations does Stephanie Royer‐Joo have?
OpenAlex counts 65 works and 1,235 citations for Stephanie Royer‐Joo, an h-index of 17, ranking #623,809 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Stephanie Royer‐Joo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.